Explore New Pattern for Chronic Disease Management in China
Pfizer has initiated some cardiovascular disease management programs to address
public health challenges. Pfizer has collaborated with the government, healthcare
providers and institutions to explore innovative solutions to improve the cardiovascular
disease management in China. On April 16th, 2013, the 4th Chinese Chronic Disease
Management Conference 2013 was successfully held in Beijing. Pfizer China regional
president Dr. Wu Xiaobing made an appeal to the public to pay attention to heart
and brain health on the conference. Pfizer China launched three government-led initiatives
about chronic diseases prevention and control:
1. carry on a national dyslipidemia screening
2. establish a national day about chronic disease prevention and control
3.implement effective measures for tobacco control
Pfizer calls on for multilateral cooperation to jointly promote chronic disease
management to create a healthier China in 2020!
Support Capital Healthcare Sustainable Development
A Health Development Symposium, which was supported by Pfizer China and hosted by
the Beijing Institute of Health Economics, was successfully held in Beijing on July
31, 2013. The symposium focused on key health development topics and greatly enhanced
healthcare management and related academic researches. The Symposium also lent support
to healthcare development in Beijing.
Explore Women Tobacco Control Module
Pfizer China supported Chinese Association on Tobacco Control to a series of women
tobacco control programs from 2012 to 2013. The programs collected signatures of
600 women celebrities who called on women nationwide to stop second-hand smoking.
More than 1,600 women maternity and community healthcare professionals as well as
enterprise delegates in Beijing have received tobacco control trainings.